4.6 Article

Approach for the Design of Covalent Protein Kinase Inhibitors via Focused Deep Generative Modeling

Related references

Note: Only part of the references are listed.
Review Biotechnology & Applied Microbiology

Trends in kinase drug discovery: targets, indications and inhibitor design

Misty M. Attwood et al.

Summary: The article analyzes the landscape of approved and investigational therapies that target kinases, highlighting the increasing importance of kinase inhibitors in oncology and beyond. It discusses trends in kinase inhibitor design and points out that there are still substantial unexplored opportunities for this drug class.

NATURE REVIEWS DRUG DISCOVERY (2021)

Editorial Material Chemistry, Medicinal

Artificial Intelligence in Drug Discovery: Into the Great Wide Open

Jurgen Bajorath et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

REINVENT 2.0: An AI Tool for De Novo Drug Design

Thomas Blaschke et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

Article Chemistry, Medicinal

Shape-Based Generative Modeling for de Novo Drug Design

Miha Skalic et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)

Article Chemistry, Multidisciplinary

Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks

Marwin H. S. Segler et al.

ACS CENTRAL SCIENCE (2018)

Review Chemistry, Multidisciplinary

The Cysteinome of Protein Kinases as a Target in Drug Development

Apirat Chaikuad et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)

Review Chemistry, Medicinal

The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review

Chengyuan Liang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Pharmacology & Pharmacy

Ibrutinib: A Review in Chronic Lymphocytic Leukaemia

Emma D. Deeks

DRUGS (2017)

Article Biochemistry & Molecular Biology

The ChEMBL bioactivity database: an update

A. Patricia Bento et al.

NUCLEIC ACIDS RESEARCH (2014)

Review Oncology

Targeting Bruton's tyrosine kinase in B cell malignancies

Rudi W. Hendriks et al.

NATURE REVIEWS CANCER (2014)

Review Biotechnology & Applied Microbiology

The resurgence of covalent drugs

Juswinder Singh et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

Article Chemistry, Medicinal

Extended-Connectivity Fingerprints

David Rogers et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)

Article Chemistry, Medicinal

LigandScout: 3-d pharmacophores derived from protein-bound Ligands and their use as virtual screening filters

G Wolber et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)

Article Biochemistry & Molecular Biology

The Protein Data Bank

HM Berman et al.

NUCLEIC ACIDS RESEARCH (2000)